BG Medicine, Inc. (BGMD) - Product Pipeline Analysis, 2016 Update

Date: June 1, 2016
Pages: 30
Price:
US$ 750.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: B77E0219995EN
Leaflet:

Download PDF Leaflet

BG Medicine, Inc. (BGMD) - Product Pipeline Analysis, 2016 Update
Summary

BG Medicine, Inc. (BGM) formerly Beyond Genomics, Inc. is a medical device company that discovers, develops and delivers diagnostic solutions. The company offers diagnostics to aid in the clinical management of heart failure and related disorders. It offers test products which includes BGM Galectin-3. BGM’s BGM Galectin-3 is a diagnostic test, which measures galectin-3 levels in blood plasma or serum. The company’s BGM Galectin-3 test is available in Europe as an aid in assessing the prognosis of patients diagnosed with acute and chronic heart failure. It caters its products to healthcare providers. BGM is headquartered in Waltham, Massachusetts, the US.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company BG Medicine, Inc.
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
BG Medicine, Inc. Company Snapshot
BG Medicine, Inc. Company Overview
BG Medicine, Inc. Pipeline Products and Clinical Trials Overview
BG Medicine, Inc. – Pipeline Analysis Overview
Key Facts
BG Medicine, Inc. - Major Products and Services
BG Medicine, Inc. Pipeline Products by Development Stage
BG Medicine, Inc. Pipeline Products Overview
BGM Galectin-3 Test - Adverse Cardiovascular Events
BGM Galectin-3 Test - Adverse Cardiovascular Events Product Overview
Biomarkers - Enbrel Treatment
Biomarkers - Enbrel Treatment Product Overview
Biomarkers - Humira Treatment
Biomarkers - Humira Treatment Product Overview
Biomarkers - Remicade Treatment
Biomarkers - Remicade Treatment Product Overview
Diagnostic Assay - Multiple Sclerosis
Diagnostic Assay - Multiple Sclerosis Product Overview
LipidDx
LipidDx Product Overview
Molecular Diagnostic Test For Avandia Treatment
Molecular Diagnostic Test For Avandia Treatment Product Overview
BG Medicine, Inc. - Key Competitors
BG Medicine, Inc. - Key Employees
BG Medicine, Inc. - Locations And Subsidiaries
Head Office
Recent Developments
BG Medicine, Inc., Recent Developments
Dec 23, 2015: BG Medicine Withdraws 510(k) Premarket Notification for Proposed Additional Indication for the BGM Galectin-3 Test
Nov 17, 2015: BG Medicine Reports Third Quarter 2015 Financial Results
Sep 15, 2015: BG Medicine to Begin Trading on the OTCQB
Aug 14, 2015: BG Medicine Reports Second Quarter 2015 Financial Results
May 14, 2015: BG Medicine Reports First Quarter 2015 Financial Results
Mar 31, 2015: BG Medicine Reports 2014 Fourth Quarter and Year End Financial Results
Mar 31, 2015: BG Medicine Submits 510(k) to FDA for Additional Indication for the BGM Galectin-3 Test
Mar 26, 2015: BG Medicine Welcomes Major Publication on the BioImage Study in the Journal of the American College of Cardiology
Feb 02, 2015: BG Medicine Announces Receipt of Favorable NASDAQ Listing Determination
Nov 20, 2014: BG Medicine, Welcomes Presentation of Clinical Data on Galectin-3 Testing at the American Heart Association 2014 Scientific Sessions Conference
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

BG Medicine, Inc. Pipeline Products and Clinical Trials Overview
BG Medicine, Inc. Pipeline Products by Equipment Type
BG Medicine, Inc. Pipeline Products by Indication
BG Medicine, Inc., Key Facts
BG Medicine, Inc., Major Products and Services
BG Medicine, Inc. Number of Pipeline Products by Development Stage
BG Medicine, Inc. Pipeline Products Summary by Development Stage
BGM Galectin-3 Test - Adverse Cardiovascular Events - Product Status
BGM Galectin-3 Test - Adverse Cardiovascular Events - Product Description
Biomarkers - Enbrel Treatment - Product Status
Biomarkers - Enbrel Treatment - Product Description
Biomarkers - Humira Treatment - Product Status
Biomarkers - Humira Treatment - Product Description
Biomarkers - Remicade Treatment - Product Status
Biomarkers - Remicade Treatment - Product Description
Diagnostic Assay - Multiple Sclerosis - Product Status
Diagnostic Assay - Multiple Sclerosis - Product Description
LipidDx - Product Status
LipidDx - Product Description
Molecular Diagnostic Test For Avandia Treatment - Product Status
Molecular Diagnostic Test For Avandia Treatment - Product Description
BG Medicine, Inc., Key Employees

LIST OF FIGURES

BG Medicine, Inc. Pipeline Products by Equipment Type
BG Medicine, Inc. Pipeline Products by Development Stage

COMPANIES MENTIONED

Corium International, Inc.
Cellceutix Corporation
Biogen Idec Inc.
Myriad Genetics, Inc.
Skip to top


Ask Your Question

BG Medicine, Inc. (BGMD) - Product Pipeline Analysis, 2016 Update
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: